Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview

Published:2012-06-23 Issue:4 Volume:11 Page:659-670
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Angeli Fabio¹,Reboldi Gianpaolo²,Mazzotta Giovanni³,Poltronieri Cristina¹,Verdecchia Paolo³

Affiliation:

1. Hospital Media Valle del Tevere – Pantalla, AUSL 2 Umbria, Department of Cardiology, Section of Cardiology, Perugia, Italy ;

2. University of Perugia, Department of Internal Medicine, Perugia, Italy

3. Hospital of Assisi, Department of Internal Medicine, Assisi, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.2012.696608

Reference75 articles.

2. Structure-based design of aliskiren, a novel orally effective renin inhibitor

3. Renin-Angiotensin System and Atherothrombotic Disease

4. The multiple actions of angiotensin II in atherosclerosis

5. The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study;Journal of Biomolecular Structure and Dynamics;2021-09-13

2. Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise;American Journal of Cardiovascular Drugs;2019-02-04

3. Anti-fibrotic treatments: A review of clinical evidence;Matrix Biology;2018-08

4. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States;American Journal of Cardiovascular Drugs;2017-08-04

5. Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial;PLOS ONE;2016-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3